✦ LIBER ✦

Concept and organization of a clinical gene therapy lab

✍ Scribed by Ellen L. W. Kittler; Peter J. Quesenberry

Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 606 KB
Volume: 58
Category: Article
ISSN: 0730-2312
DOI: 10.1002/jcb.240580402

No coin nor oath required. For personal study only.

✦ Synopsis

Designing a dedicated clinical facility to meet the needs of existing and developing Gene Therapy Protocols presents a unique challenge. Here, we review some of the issues we faced and share some of our design concepts. An optimal Clinical Gene Therapy Lab must meet relevant regulatory guidelines, interface with other hospital labs as well as the clinic and patient care areas, be efficient and flexible in utilization of space, and have the potential to meet future needs without continual renovation. As clinical science expands to include more gene transfer approaches, specific laboratory areas for this type of work will become increasingly necessary.

📜 SIMILAR VOLUMES

Gene therapy and gastrointestinal cancer

Gene therapy and gastrointestinal cancer: concepts and clinical facts

✍ Martin Hauses; Hans K. Schackert 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 52 KB

Gene therapy for pain: Results of a phas

Gene therapy for pain: Results of a phase I clinical trial

✍ David J. Fink; James Wechuck; Marina Mata; Joseph C. Glorioso; James Goss; David 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 235 KB 👁 2 views

## Abstract ## Objective: Preclinical evidence indicates that gene transfer to the dorsal root ganglion using replication‐defective herpes simplex virus (HSV)‐based vectors can reduce pain‐related behavior in animal models of pain. This clinical trial was carried out to assess the safety and explo

A physiologic concept of hypoglycemia an

A physiologic concept of hypoglycemia and convulsive therapy

✍ Mildred Squires; Sidney J. Tillim 📂 Article 📅 1944 🏛 Springer US 🌐 English ⚖ 759 KB

Guidelines for the design and implementa

Guidelines for the design and implementation of clinical studies in somatic cell therapy and gene therapy

✍ A. Lindemann; F. M. Rosenthal; R. Mertelsmann; S. Hase; P. Markmeyer 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 443 KB

According to Sects. 2 and 3 of the German drug statute, (Arzneimittelgesetz, AMG) gene technology and gene therapy products as well as somatic cell therapy products are regarded as drugs and are therefore subject to Sects. 40 and 41, stipulating the requirements for clinical studies designed to test

An early cautious step toward clinical l

An early cautious step toward clinical liver-specific gene therapy

✍ A A Demetriou 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB

An inventory of shedding data from clini

An inventory of shedding data from clinical gene therapy trials

✍ Ellen A. M. Schenk-Braat; Marjolein M. K. B. van Mierlo; Gerard Wagemaker; Chris 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

## Abstract Viruses are the most commonly used vectors for clinical gene therapy. The risk of dissemination of a viral vector into the environment via excreta from the treated patient, a phenomenon called shedding, is a major safety concern for the environment. Despite the significant number of cli